Skip to content

A cohort study of the association between B-lymphocyte subsets and the prognosis of initial adult primary nephrotic syndrome

A cohort study of the association between B-lymphocyte subsets and the prognosis of initial adult primary nephrotic syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092780
Enrollment
Unknown
Registered
2024-11-22
Start date
2024-08-01
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

idiopathic nephrotic syndrome

Interventions

Remission group/ Non-remission group:none

Sponsors

Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1) Primary nephrotic syndrome (MCD, IMN); 2) older than 18 years old; 3) the eGFR > 40 ml/min, urine protein > 3.5 g/d , albumin <30 g/L; 4) no use of hormone and immune inhibitors and previous history of RTX; 5)Voluntary informed consent signed enters.

Exclusion criteria

Exclusion criteria: 1) secondary nephrotic syndrome patients; 2) with lymphoma, SLE, RA, diseases such as hepatitis b, hepatitis c, HIV patients; 3) RTX or mouse protein allergy; 4) patients with severe active infection; 5) immune response to severe damage, such as low gamma globulin hematic disease, severe CD4 / CD8 cells number decrease) patients. 6) patients with severe heart failure (NYHA class ?); 7) patients treated with corticosteroids and immunosuppressants (including CNI, CTX) or RTX; 8) pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Whether there is relief, whether there is recurrence after relief, the time and frequency of the first recurrence;

Secondary

MeasureTime frame
Relief rate, recurrence rate, and number of B cell subpopulations;

Countries

China

Contacts

Public ContactHaiYing Song

Department of Nephrology, Shenzhen Second People's Hospital

haiyingsong2024@126.com+86 158 8977 6913

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026